Clinical trials for Ganglioneuroblastoma
14 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT07502287Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory NeuroblastomaBeijing Biotech
- RECRUITINGPhase 3NCT07375563Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and GanglioneuroblastomaFederal Research Institute of Pediatric Hematology, Oncology and Immunology · PI: Tatyana V Shamanskaya, MD, PHD
- RECRUITINGPhase 3NCT06172296Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaNational Cancer Institute (NCI) · PI: Sara M Federico
- RECRUITINGN/ANCT05192980SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic TumoursInstitut Curie
- RECRUITINGNCT06296732Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors StratificationFederal Research Institute of Pediatric Hematology, Oncology and Immunology
- RECRUITINGPhase 3NCT06071897Induction Chemoimmunotherapy for Patients With High-risk NeuroblastomaFederal Research Institute of Pediatric Hematology, Oncology and Immunology
- ACTIVE NOT RECRUITINGPhase 2NCT04385277Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)Children's Oncology Group · PI: Ami V Desai
- ACTIVE NOT RECRUITINGEarly Phase 1NCT04040088An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsMayo Clinic · PI: Nadia Laack, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03786783Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk NeuroblastomaNational Cancer Institute (NCI) · PI: Sara M Federico
- RECRUITINGPhase 3NCT03126916Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology Group · PI: Steven G DuBois
- ACTIVE NOT RECRUITINGPhase 1NCT02311621Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01Seattle Children's Hospital · PI: Catherine Albert, MD
- ACTIVE NOT RECRUITINGPhase 3NCT02176967Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk NeuroblastomaChildren's Oncology Group · PI: Holly J Meany
- RECRUITINGN/ANCT02112617Phase II Study of Proton Radiation Therapy for NeuroblastomaMassachusetts General Hospital · PI: Shannon M. MacDonald, MD
- ACTIVE NOT RECRUITINGNCT00904241Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or GanglioneuroblastomaChildren's Oncology Group · PI: Michael Hogarty